Adon Health has built a healthcare platform that offers lab testing, physician consultations, medication delivery, and therapy management with a focus on testosterone replacement therapy for men. It is designed to enable patients to manage their care digitally and in one place, making it significantly less complex and time-consuming than the current standard. Startup not limited to testosterone replacement therapies. In the future, Adon Health plans to offer additional digital health services and preventive medicine for men.
The startup was founded at the end of 2023 by two former McKinsey colleagues, Maximilian Schubert and Dr. Jonathan Apasu. After completing a beta test phase, the platform already started and supports its first patients in the German market. The startup has now successfully completed its first round of financing, raising an undisclosed six-figure sum. The Swiss VC fund Backbone Ventures is leading the pre-seed round. Also participating are Vera Baker from the Atomico Angel Program and several business angels with experience in building companies in the European healthcare and B2C ecosystem.
Maximilian Schubert, co-founder of Adon Health, explains:
"We have an opportunity to provide millions of patients with better, more modern healthcare that meets 21st-century technological standards. We want to enable patients to use a platform that makes the healthcare experience as modern and user-centric as using an iPhone. More importantly, however, we want to play a central role in raising Europe-wide awareness of major, underserved health problems like testosterone deficiency and helping people not only reactively but also preventively."
Adon Health aims to “shape how millions of people in Europe receive healthcare”
Co-founder and doctor Jonathan Apasu added:
"During our interactions with patients, we have observed the serious problems that complex care processes can cause for those affected. We want to help shape how millions of people in Europe receive healthcare. The opportunities created by technology in recent decades are abundant. We want to make them accessible to patients while maintaining the highest medical standards and collaborating with all parts of the conventional healthcare ecosystem. Applying such a model for testosterone deficiency is just the beginning. Patient-centered digital innovation, especially in more complex care processes, has been lacking in recent years. We are confident that there are major benefits for healthcare in Europe."
Jan Claudio Muñoz, Partner at Backbone Ventures, is convinced of Adon Health:
"We see great potential in simplifying complex and underserved care processes with a vertically integrated healthcare platform. The healthcare ecosystem has changed – with important regulatory changes in telemedicine and record usage rates of online services, a new era for digital solutions is dawning. We have the opportunity to create significant added value for patients with technological innovations. Yet, particularly in Europe, men's healthcare provision has barely changed, despite the clear need for new solutions that address men's inadequate healthcare standards."
